HomeIDIA • SWX
add
Idorsia Ltd
Previous close
CHF 1.49
Day range
CHF 1.35 - CHF 1.50
Year range
CHF 0.61 - CHF 2.98
Market cap
320.81M CHF
Avg Volume
902.79K
P/E ratio
-
Dividend yield
-
Primary exchange
SWX
Market news
Financials
Income Statement
Revenue
Net income
(CHF) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 58.88M | 485.38% |
Operating expense | 51.23M | -24.02% |
Net income | 63.12M | 111.38% |
Net profit margin | 107.19 | -63.89% |
Earnings per share | — | — |
EBITDA | -17.91M | 80.07% |
Effective tax rate | 0.62% | — |
Balance Sheet
Total assets
Total liabilities
(CHF) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 64.85M | -81.34% |
Total assets | 456.17M | -41.56% |
Total liabilities | 1.59B | -7.50% |
Total equity | -1.13B | — |
Shares outstanding | 203.29M | — |
Price to book | -0.27 | — |
Return on assets | -11.56% | — |
Return on capital | -67.01% | — |
Cash Flow
Net change in cash
(CHF) | Mar 2025info | Y/Y change |
---|---|---|
Net income | 63.12M | 111.38% |
Cash from operations | -60.67M | 48.71% |
Cash from investing | 6.86M | -97.77% |
Cash from financing | -1.65M | — |
Net change in cash | -55.70M | -129.35% |
Free cash flow | -120.13M | -349.05% |
About
Idorsia is a Swiss pharmaceutical research company in Allschwil, near Basel, Switzerland. Wikipedia
Founded
2017
Website
Employees
938